Together with our US partner Cardiovascular Clinical Sciences(CCS), we exhibited at #HFSA2022!
Dr. Lorenzo DiCarlo MD, cardiologist and medical lead at #LivaNova for the #ANTHEM-HFrEF Pivotal Study (NCT03425422), visited us to discuss industry-leading cardiovascular research.
Hans-Dirk Duengen MD PhD, CEO and Chief Scientific Officer of #Scirent, and Lorenzo Di Carlo MD, cardiologist and medical lead at #LivaNova for the #ANTHEM-HFrEF Pivotal Study, traveling to meet participating clinical investigators at their study sites across Europe.
We acknowledge the privilege of being able to get #vaccinated. That's why for each #vaccine dose received by one of our team members, SCIRENT #donates at least 3 vaccine doses to developing countries. Vaccine equity will accelerate the end of the pandemic.
#COVAX
We are thrilled to be part of the #AHA21 scientific session from November 13-15, 2021. Book an appointment with our leadership at our virtual booth to learn more about our industry-leading cardiovascular research services.
Meet Us Here
https://t.co/ch3mHiBYxt
SCIRENT is proud to appoint Dr. Maximilian Posch as Chief Medical Officer. He will be an important driver of SCIRENT's growth by contributing medical and scientific expertise to support SCIRENT's service portfolio.
👉 Press release: https://t.co/x4wFciyxAO
#cro#cardiology
Our highly educated staff with a problem-solving mindset
manages to navigate complexity in clinical trials and reach sponsor objectives on time. Hands-on leadership team involved in all aspects of study progress, ready to give advice or implement feedback quickly.
Accelerate your Research in Cardiovascular and Medical Device Trials. We share your enthusiasm for finding efficient therapies. SCIRENT works with pharmaceutical, biotech, and medical device companies across all phases of clinical trial management.
For our German speaking community:
Der Podcast "Hand aufs Herz" wird von zwei erfahrenen Fachärzten der Kardiologie und dem selbsternannten Laien der Nation – Thomas Krug herausgebracht. Hört mal rein: https://t.co/tbHizAO7ZV
#Podcast#Kardiologie#Cardiovascular#Medizin
We are looking for a motivated CRA with excellent Italian language skills. Are you interested in joining our young and dedicated international team?
Apply now: https://t.co/zzHliq7u6y
@BerlinHeals innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure. SCIRENT conducted the first-in-human pilot study for this device. We are proud to support Berlin Heals in this trial.
Learn more: https://t.co/RIB63ZRLl4
@BerlinHeals innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure. SCIRENT conducted the first-in-human pilot study for this device. We are proud to support Berlin Heals in this trial.
Learn more: https://t.co/RIB63ZRLl4
Randomization of the first 300 patients represents an important milestone for the ANTHEM-HFrEF Pivotal Study https://t.co/V7skVpUQBk
Congratulations to the clinical team! SCIRENT is proud to support this important clinical trial with our expertise.
#heartfailure#clinicaltrial
"Restarting by Design: Agile Crisis Management for Rapid Resumption of #Cardiovascular Clinical Trials"
Join our Webinar:
May 25th,
4 pm (CEST) and 8 pm (CEST)
#SCIRENT just donated to the #COVID19Fund to support @WHO's response efforts to the global #COVID19 pandemic. Join us to help combat this growing global threat to people's health and well-being.
Exciting news: We received the world’s first authorization of a #COVID19#vaccine, with @MHRA granting emergency use authorization in the UK. More regulatory decisions may come in 2020. More information: https://t.co/8Fpa22leS5
#SCIRENT operations continue at full capacity. Effective #measures against #COVID19 have been implemented, including:
✅rapid testing for employees🧪
✅face masks 😷
✅ventilation systems 🪟
✅social distancing 📏
✅increased hand hygiene 🧼
#SCIRENT is growing 💪- do not miss to join us. 😱
We would love to have you on board and share our experience with you. Together we will be great. 🙌
We are looking for YOU! 🔭